Lv1
50 积分 2024-09-04 加入
The IL-33/ST2 pathway: therapeutic target and novel biomarker
11天前
已完结
The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus
12天前
已完结
The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment
12天前
已完结
Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients
12天前
已完结
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
3个月前
已完结
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
3个月前
已完结
Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody
3个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
5个月前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
10个月前
已完结
Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody–Drug Conjugates
10个月前
已完结
皖公网安备34019202002308
